These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 14209555

  • 1. EXPERIENCES WITH CHEMOTHERAPY IN GYNECOLOGIC CANCER.
    HRESCHCHYSHYN MM.
    N Y State J Med; 1964 Oct 01; 64():2431-4. PubMed ID: 14209555
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. THE TREATMENT OF CANCER BY ISOLATION PERFUSION.
    DONALDSON SS, FLETCHER WS.
    Am J Nurs; 1964 Aug 01; 64():81-4. PubMed ID: 14180364
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
    KONDO T.
    Acta Unio Int Contra Cancrum; 1964 Aug 01; 20():194-8. PubMed ID: 14151882
    [No Abstract] [Full Text] [Related]

  • 6. CHLORAMBUCIL-PREDNISOLONE THERAPY FOR DISSEMINATED BREAST CARCINOMA.
    FRECKMAN HA, FRY HL, MENDEZ FL, MAURER ER.
    JAMA; 1964 Jul 06; 189():23-6. PubMed ID: 14149018
    [No Abstract] [Full Text] [Related]

  • 7. CANCER CHEMOTHERAPY.
    EISMAN SG, RICHARDSON FM.
    Med Sci; 1964 Mar 06; 15():63-72. PubMed ID: 14143132
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL, Blessing JA, DiSaia PJ, Soper JT, Twiggs LB.
    Obstet Gynecol; 1989 Mar 06; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy of malignant disease. I. Solid tumours.
    REEVE TS.
    Med J Aust; 1962 Dec 01; 49(2)():867-70. PubMed ID: 13973605
    [No Abstract] [Full Text] [Related]

  • 14. CHEMOTHERAPY IN WOMEN WITH TROPHOBLASTIC DISEASE: CHORIOCARCINOMA, CHORIOADENOMA DESTRUENS, AND COMPLICATED HYDATIDIFORM MOLE.
    HERTZ R, ROSS GT, LIPSETT MB.
    Ann N Y Acad Sci; 1964 Apr 02; 114():881-5. PubMed ID: 14131933
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. STUDIES ON HUMAN MELANOMA CELLS IN TISSUE CULTURE. II. EFFECTS OF SEVERAL CANCER CHEMOTHERAPEUTIC AGENTS ON CYTOLOGY AND GROWTH.
    COBB JP, WALKER DG.
    Acta Unio Int Contra Cancrum; 1964 Apr 02; 20():206-8. PubMed ID: 14151886
    [No Abstract] [Full Text] [Related]

  • 17. IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. 3. PRELIMINARY STUDIES OF SPONTANEOUS MAMMARY TUMORS IN MICE.
    DIPAOLO JA.
    Cancer Chemother Rep; 1965 Feb 02; 44():19-24. PubMed ID: 14294807
    [No Abstract] [Full Text] [Related]

  • 18. IN VITRO CULTURE OF YOSHIDA SARCOMA CELLS: METHODS FOR DETERMINING ACQUIRED RESISTANCE TO DRUGS.
    SAKURAI Y.
    Natl Cancer Inst Monogr; 1964 Dec 02; 16():207-39. PubMed ID: 14235655
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.